CAS: 1931944-80-7
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | Donanemab REF: TM-T77162CAS: 1931944-80-7 | 95% | 216.00 €~2,460.00 € | Wed 16 Apr 25 |
 | Donanemab REF: 3D-CLA1552CAS: 1931944-80-7 | - - - | To inquire | Mon 28 Apr 25 |
Donanemab
CAS:1931944-80-7
Donanemab (LY3002813), a humanized IgG1 antibody, targets N-terminal Aβ for potential early Alzheimer's research.
Purity:
95%
Color and Shape:
Liquid
Ref: TM-T77162
| 1mg | 216.00 € | ||
| 5mg | 560.00 € | ||
| 10mg | 912.00 € | ||
| 25mg | 1,349.00 € | ||
| 50mg | 1,825.00 € | ||
| 100mg | 2,460.00 € |
Estimated delivery in United States, on Wednesday 16 Apr 2025
Donanemab
CAS:1931944-80-7
A humanized IgG1 monoclonal antibody targets Aβ N-terminal epitope (p3-42).
Ref: 3D-CLA1552
| Undefined size | To inquire |
Estimated delivery in United States, on Monday 28 Apr 2025
